文献速递胃肠外科肝胆胰外科疝与腹壁外科

新型机器人平台单术者手术的安全性与可行性:IDEAL 2a 开发研究

Safety and feasibility of solo surgery using a novel robotic platform: an IDEAL 2a development study.
PubMed 文献 · Surg Endosc · 2025-10-13

本研究为 IDEAL 2a 前瞻性多中心观察研究,评估 Maestro 机器人系统用于单术者腹部手术的安全性与可行性。结果显示无设备相关不良事件,中转多孔腹腔镜 1 例(2.2%),轻微并发症 3 例(6.6%),无再入院、再手术或死亡。

要点

  • Maestro 平台在常规与复杂腹部手术中单术者操作安全可行。
  • 无设备相关不良事件,中转多孔腹腔镜率 2.2%,轻微并发症率 6.6%。
  • 平均机器人装机时间 6.1 分钟,平均手术时间 43.6 分钟。

核心结论

  • Maestro 平台用于单术者手术安全可行,在常规和复杂手术中安全性与技术结果可接受。

主要发现

  • 患者平均年龄 55.3(SD 18.1)岁,平均 BMI 29.4(8.1)kg/m2,男性占 1/3、女性占 2/3。
  • 主要手术指征为胆囊炎(n=17,37.8%)、肥胖(n=10,22.1%)和腹股沟疝(n=11,24.4%)。
  • 最常见术式为胆囊切除术(n=17,37.8%)、腹股沟疝手术(n=11,24.4%)和袖状胃切除术(n=5,11.1%)。
  • 平均总手术室时间 95.5(SD 38.3)分钟,平均手术时间 43.6(SD 30.6)分钟,平均机器人装机时间 6.1(SD 4.1)分钟。
  • 1 例(2.2%)中转多孔腹腔镜,无病例需增加穿刺孔或床旁助手;平均住院时间 <1(SD 1.3)天;轻微并发症 3 例(6.6%),无再入院、再手术或死亡,无设备相关不良事件。

临床怎么用

  • 该平台可用于胆囊切除、腹股沟疝修补和袖状胃切除等腹部手术的单术者操作,但需在受控研究背景下进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive surgery is the standard of care for general surgical procedures. While use continues to grow, current platforms are hindered by prolonged operative times, high costs, steep learning curves, and lack of surgeon autonomy, which restricts expansion and practicality in high-volume and ambulatory surgery centers. Our goal was to evaluate the safety and feasibility of a novel AI-powered robotic platform to perform solo surgery. METHODS: An IDEAL framework 2a prospective, multi-center observational study was performed on consecutive patients planned for solo abdominal surgery using the Maestro™ robotic system (Moon Surgical SAS, Paris, France) from 10/2023 to 4/2025. Preoperative, intraoperative, postoperative, and device-specific variables were evaluated. Descriptive statistics were used to summarize outcome measures. RESULTS: Forty-five procedures were performed by five surgeons. Patients had a mean age of 55.3 (SD 18.1) years and a mean BMI of 29.4 (8.1) kg/m2. The cohort was 1/3 male and 2/3 female. The main indications for operation were cholecystitis (n = 17, 37.8%), obesity (n = 10, 22.1%), and inguinal hernia (n = 11, 24.4%). The most common cases were cholecystectomy (n = 17, 37.8%), inguinal hernia (n = 11, 24.4%), and sleeve gastrectomy (n = 5, 11.1%). The mean total room time was 95.5(SD 38.3) minutes, the mean operative time was 43.6(SD 30.6) minutes, and the mean robotic setup time was 6.1(SD 4.1) minutes. One case required conversion to multiport laparoscopy (2.2%). No cases required insertion of additional ports or a bedside assistant. The mean length of stay was < 1 (SD 1.3) day. There was minor morbidity in 3 (6.6%) patients, but no readmissions, reoperations, or mortality. There were no device-related adverse events. CONCLUSION: This IDEAL 2a investigation showed the Maestro platform was safe and feasible for performing solo surgery, with acceptable safety and technical outcomes in routine and complex procedures. There is potential to improve operating room workflow and surgeon autonomy, with controlled studies to follow.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Mercoli H, Tzedakis S, Cadière B, et al. Safety and feasibility of solo surgery using a novel robotic platform: an IDEAL 2a development study. Surg Endosc. 2025. PMID: 41083613. doi:10.1007/s00464-025-12271-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。